"10.1371_journal.pone.0017556","plos one","2011-03-03T00:00:00Z","Nicolas Veziris; Murad Ibrahim; Nacer Lounis; Koen Andries; Vincent Jarlier","UPMC Université Paris 06, EA 1541, laboratoire de Bactériologie-Hygiène, Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, laboratoire de Bactériologie-Hygiène, Paris, France; Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France; Department of Microbiology & Immunology, Faculty of Medicine, Al-Quds University Abu Dies, Jerusalem, Palestine; Department of Antimicrobial Research, Tibotec BVBA, Beerse, Belgium","Conceived and designed the experiments: NV MI NL KA VJ. Performed the experiments: NV MI. Analyzed the data: NV MI NL KA VJ. Contributed reagents/materials/analysis tools: NV MI NL. Wrote the paper: NV MI NL KA VJ.","The authors have the following patent to declare for TMC 207: US 7,498,343 B2; date of patent: March, 3, 2009. KA and NL are employees of Tibotec BVBA, a subsidiary of Johnson and Johnson. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","03","Nicolas Veziris","NV",5,TRUE,5,2,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
